News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on OncoSil Medical.
RELATED STOCKHEAD STORIES
News
Top 10 at 10: Big bagging health stocks and some impressive (unstimulated) gas flow
News
Rise and Shine: Everything you need to know before the ASX opens
News
In Case You Missed It: A cap raise and renewed gold exploration licence seal the deal today
News
In Case You Missed It: R&D refunds for drug developers and a major uranium merger
Health & Biotech
ASX Health Stocks: Oncosil advances pancreatic cancer device to Greece, its third potential market in Europe
News
Market Highlights: AI stocks up as Google unveils ChatGPT’s rival Gemini, and 5 ASX small caps to watch
News
Market Highlights: Dovish comments from Fed, gold nears all-time high, and 5 ASX small caps to watch
News
In Case You Missed It: High grade gold for the win
Health & Biotech
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads
Health & Biotech
ASX Health Stocks: OncoSil to commence trial; Korea and Malaysia next stops for these biotechs
Health & Biotech
ASX Health Stocks: Clarity reveals Phase 1 success; Starpharma and Oncosil head for Asia
Health & Biotech
ASX Health Stocks: HeraMED up 17pc and Mesoblast 12pc after strong study results
Health & Biotech
ASX Health Stocks: HitIQ and Volpara prove world class technology after signing major US deals
News
Top 10 at 10: These ASX stocks are out front in a flash
News
Closing Bell: Welcome to the palladium and uranium show
Health & Biotech
Who’s carrying on the Cochlear legacy? The ASX med device stocks that could soar from tailwinds
Health & Biotech